Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas

Epigenetics

Volumn 10, Issue 3, 2015, Pages 213-220

  Alholle, A ^a   Brini, A T ^b,c   Bauer, J ^d   Gharanei, S ^a   Niada, S ^b,c   Slater, A ^a   Gentle, D ^a   Maher, E R ^a   Jeys, L ^a   Grimer, R ^a   Sumathi, V P ^a   Latif, F ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Chordomas; DNA; HumanMethylation450 BeadChips; Methylation; Non recurrent; Recurrent

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC ANTIMETABOLITE; AZACITIDINE; DECITABINE;

ADULT; AGED; ANALYSIS; ARTICLE; CANCER RECURRENCE; CARCINOGENESIS; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR ASSEMBLY; CELLULAR ORGANIZATION; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CHORDOMA; CONTROLLED STUDY; CPG ISLAND; DNA FINGERPRINTING; DNA METHYLATION; DNA RECOMBINATION; DNA REPAIR; DNA REPLICATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; INGENUITY PATHWAY ANALYSIS; MALE; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANALOGS AND DERIVATIVES; BONE TUMOR; DRUG EFFECTS; GENETICS; GENOME; MIDDLE AGED; RECURRENT DISEASE; TUMOR CELL LINE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BONE NEOPLASMS; CELL LINE, TUMOR; CHORDOMA; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENOME; HUMANS; MALE; MIDDLE AGED; RECURRENCE;

EID: 84925302520     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2015.1006497     Document Type: Article

References (29)

1. Walcott BP, Nahed BV, Mohyeldin A, Coumans JV, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol 2012; 13:e69-76; PMID:22300861; http://dx.doi.org/10.1016/S1470-2045(11)70337-0.
2. Williams BJ, Raper DM, Godbout E, Bourne TD, Prevedello DM, Kassam AB, Park DM. Diagnosis and treatment of chordoma. J Natl Compr Canc Netw 2013; 11:726-31; PMID:23744869.
3. Yakkioui Y, van Overbeeke JJ, Santegoeds R, van Engeland M, Temel Y. Chordoma: the entity. Biochim Biophys Acta 2014; 1846:655-69; PMID:25193090.
4. Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, Boshoff C, Flanagan AM. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 2006; 209:157-65; PMID:16538613; http://dx.doi.org/10.1002/path.1969.
5. Presneau N, Shalaby A, Ye H, Pillay N, Halai D, Idowu B, Tirabosco R, Whitwell D, Jacques TS, Kindblom LG, et al. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol 2011; 223:327-35; PMID:21171078; http://dx.doi.org/10.1002/path.2816.
6. Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012; 13:679-92; PMID:22945394; http://dx.doi.org/10.1038/nrg3270.
7. Richter AM, Pfeifer GP, Dammann RH. The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta 2009; 1796:114-28; PMID:19344752.
8. Stirzaker C, Taberlay PC, Statham AL, Clark SJ. Mining cancer methylomes: prospects and challenges. Trends Genet 2014; 30:75-84; PMID:24368016; http://dx.doi.org/10.1016/j.tig.2013.11.004.
9. Scheil S, Bruderlein S, Liehr T, Starke H, Herms J, Schulte M, Moller P. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, UCH1. Genes Chromosomes Cancer 2001; 32:203-11; PMID:11579460; http://dx.doi.org/10.1002/gcc.1184.
10. Rinner B, Froehlich EV, Buerger K, Knausz H, Lohberger B, Scheipl S, Fischer C, Leithner A, Guelly C, Trajanoski S, Szuhai K, Liegl B. Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1. Int J Oncol 2012; 40:443-51; PMID:22002331.
11. Siu IM, Salmasi V, Orr BA, Zhao Q, Binder ZA, Tran C, Ishii M, Riggins GJ, Hann CL, Gallia GL. Establishment and characterization of a primary human chordoma xenograft model. J Neurosurg 2012;116:801-9; PMID:22283186; http://dx.doi.org/10.3171/2011.12.JNS111123.
12. Trucco MM, Awad O, Wilky BA, Goldstein SD, Huang R, Walker RL, Shah P, Katuri V, Gul N, Zhu YJ, et al. A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-kB signaling in chordoma biology. PLoS One 2013; 8: e79950; PMID:24223206; http://dx.doi.org/10.1371/journal.pone.0079950.
13. Karikari IO, Gilchrist CL, Jing L, Alcorta DA, Chen J, Richardson WJ, Gabr MA, Bell RD, Kelley MJ, Bagley CA, et al. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines. J Neurosurg Spine 2014; 21:386-93; PMID:24905390; http://dx.doi.org/10.3171/2014.4.SPINE13262.
14. Bozzi F, Manenti G, Conca E, Stacchiotti S, Messina A, Dagrada G, Gronchi A, Panizza P, Pierotti MA, Tamborini E, Pilotti S. Development of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies. Neuro Oncol 2014; 16:72-80; PMID:24366975; http://dx.doi.org/10.1093/neuonc/not152.
15. Ahuja N, Easwaran H, Baylin SB. Harnessing the potential of epigenetic therapy to target solid tumors. J Clin Invest 2014; 124:56-63; PMID:24382390; http://dx.doi.org/10.1172/JCI69736.
16. Heyn H, M_endez-Gonz_alez J, Esteller M. Epigenetic profiling joins personalized cancer medicine. Expert Rev Mol Diagn 2013;13:473-9; PMID:23782254; http://dx.doi.org/10.1586/erm.13.36.
17. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25:315-9; PMID:10888881; http://dx.doi.org/10.1038/77083.
18. Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1995; 1:570-7; PMID:7585125; http://dx.doi.org/10.1038/nm0695-570.
19. Choi KS, Cohn MJ, Harfe BD. Identification of nucleus pulposus precursor cells and notochordal remnants in the mouse: implications for disk degeneration and chordoma formation. Dev Dyn 2008; 237:3953-8; PMID:19035356; http://dx.doi.org/10.1002/dvdy.21805.
20. Rinner B, Weinhaeusel A, Lohberger B, Froehlich EV, Pulverer W, Fischer C, Meditz K, Scheipl S, Trajanoski S, Guelly C, Leithner A, Liegl B. Chordoma characterization of significant changes of the DNA methylation pattern. PLoS One 2013; 8:e56609; PMID:23533570; http://dx.doi.org/10.1371/journal.pone.0056609.
21. Sabova L, Kretova M, Luciakova K. New insights into the role of NF1 in cancer. Neoplasma 2013; 60:233-9; PMID:23373991; http://dx.doi.org/10.4149/neo_2013_031.
22. Lin CH, Ji T, Chen CF, Hoang BH. Wnt signaling in osteosarcoma. Adv Exp Med Biol 2014; 804:33-45; PMID:24924167; http://dx.doi.org/10.1007/978-3-319-04843-7_2.
23. Medves S, Duhoux FP, Ferrant A, Toffalini F, Ameye G, Libouton JM, Poirel HA, Demoulin JB. KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia. Leukemia 2010; 24:1052-5; PMID: 20164854; http://dx.doi.org/10.1038/leu.2010.13.
24. Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, et al. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011; 29:1408-14; PMID:20823417; http://dx.doi.org/10.1200/JCO.2009.27.4324.
25. Devarajan A, Shih D, Reddy ST. Inflammation, infection, cancer and all that...the role of paraoxonases. Adv Exp Med Biol 2014; 824:33-41; PMID:25038992; http://dx.doi.org/10.1007/978-3-319-07320-0_5.
26. Gharanei S, Brini AT, Vaiyapuri S, Alholle A, Dallol A, Arrigoni E, Kishida T, Hiruma T, Avigad S, Grimer R, et al. RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma. Epigenetics 2013; 8:893-8; PMID:23887284; http://dx.doi.org/10.4161/epi.25617.
27. Alholle A, Brini AT, Gharanei S, Vaiyapuri S, Arrigoni E, Dallol A, Gentle D, Kishida T, Hiruma T, Avigad S, et al. Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma. Epigenetics 2013; 8:1198-204; PMID:24005033; http://dx.doi.org/10.4161/epi.26266.
28. Assenov Y, Muller F, Lutsik P, Walter J, Lengauer T, Bock C. Comprehensive analysis of DNA methylation data with RnBeads. Nat Methods 2014; 11:1138-40; PMID: 25262207.
29. Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, Beck S. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium450 k DNA methylation data. Bioinformatics 2013; 29:189-96; PMID: 23175756; http://dx.doi.org/10.1093/bioinformatics/bts680.